Sarepta Therapeutics Inc (SRPT)

Add to Watchlists
Create an Alert
82.30 -3.06  -3.58% NASDAQ Sep 20, 16:59 Delayed 2m USD
View Full Chart
Price Chart
View All SRPT News

News

View All Events

Events

Date Type Description
10/24/2019 16:30 EDT Misc Sarepta Therapeutics Inc Third Quarter Earnings Conference Call in 2019
10/24/2019 Earnings Sarepta Therapeutics Inc Third Quarter Earnings in 2019 Release
08/07/2019 16:30 EDT Misc Sarepta Therapeutics Inc Second Quarter Earnings Conference Call in 2019
08/07/2019 Earnings Sarepta Therapeutics Inc Second Quarter Earnings in 2019 Release
06/06/2019 09:00 EDT Misc Sarepta Therapeutics Inc Annual General Meeting in 2018
05/08/2019 16:30 EDT Misc Sarepta Therapeutics Inc First Quarter Earnings Conference Call in 2019
05/08/2019 Earnings Sarepta Therapeutics Inc First Quarter Earnings in 2019 Release
02/28/2019 Misc Sarepta Therapeutics Inc Annual Report in 2018
02/27/2019 16:30 EST Misc Sarepta Therapeutics Inc Fourth Quarter Earnings Conference Call in 2018
02/27/2019 Earnings Sarepta Therapeutics Inc Fourth Quarter Earnings in 2018 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.sarepta.com
  • Investor Relations URL: http://investorrelations.sarepta.com/phoenix.zhtml?c=64231&p=irol-irhome
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Oct. 24, 2019
  • Last Earnings Release: Aug. 07, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.

Top Fund Holders

Symbol Name Weighting
FID5820 Fidelity Canadian Growth Company Sr P2T5 3.37%
FID6641 Fidelity Canadian Growth Company Cl E4T5 3.37%
BBH VanEck Vectors Biotech ETF 2.31%
FBIOX Fidelity® Select Biotechnology 2.20%
FSPHX Fidelity® Select Health Care 2.07%
THISX T. Rowe Price Health Sciences I 1.50%
HQL Tekla Life Sciences Investors 1.43%
HQH Tekla Healthcare Investors 1.20%
LABU Direxion Daily S&P Biotech Bull 3X ETF 1.11%
IBB iShares Nasdaq Biotechnology ETF 0.87%
NAESX Vanguard Small Cap Index Inv 0.28%
VB Vanguard Small-Cap ETF 0.28%

Comparables

Edit

Excel Add-In Codes

  • Name: =YCI("SRPT","name")
  • Description: =YCI("SRPT","description")
  • Sector: =YCI("SRPT","sector")
  • Industry: =YCI("SRPT","industry")
  • Est. Current Fiscal Year End: =YCI("SRPT","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.